Removing the golden coat of Staphylococcus aureus.
Daum
Robert S
RS
Department of Pediatrics, Section of Infectious Diseases, University of Chicago, Chicago, USA.
D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000096:biosynthesis; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D013186:Farnesyl-Diphosphate Farnesyltransferase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D016106:Methicillin Resistance; D051379:Mice; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000378:metabolism / Q000472:pathogenicity; D014774:Virulence / Q000187:drug effects; D024341:Xanthophylls / Q000096:biosynthesis*
D000924:Anticholesteremic Agents; D004791:Enzyme Inhibitors; D024341:Xanthophylls; C031841:staphyloxanthin; D002784:Cholesterol; D013186:Farnesyl-Diphosphate Farnesyltransferase